AKT1 and systemic lupus erythematosus: In the lupus MRL/lpr mouse model, it was found that excessive PI3K/Akt pathway activation leads to the severity of inflammation and fibrosis in the kidney while its inhibition reduces glomerulonephritis and prolonged life span (55–57).